Atglistatin
Atglistatin is a selective adipose triglyceride lipase (ATGL) inhibitor which inhibits lipolysis with an IC50 of 0.7 μM in vitro.
Product Specifications
CAS Number
1469924-27-3
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
ATGL
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/Atglistatin.html
Purity
99.44
Solubility
DMSO : ≥ 100 mg/mL
Smiles
O=C(NC1=CC(C2=CC=C(N(C)C)C=C2)=CC=C1)N(C)C
Molecular Formula
C17H21N3O
Molecular Weight
283.37
Precautions
H302, H315, H319, H335
References & Citations
[1]Mayer N, et al. Development of small-molecule inhibitors targeting adipose triglyceride lipase. (2013) Nat Chem Biol. 9 (12) :785-7.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY421430 100 µg
Constitutive androstane receptor (NR1I3) (NM_001077475) Human Over-expression Lysate
Sign In for Pricing
View Details 
LY402430 100 µg
RIPK5 (DSTYK) (NM_015375) Human Over-expression Lysate
Sign In for Pricing
View Details ![PE Anti-Human HLA-DR Antibody[L243]](https://cdn.genprice.uk/products/763/68dd14b2061270361e7d41a5/imageurl/e-ab-f1111d.webp)